111 related articles for article (PubMed ID: 8636265)
1. Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis.
Bettica P; Taylor AK; Talbot J; Moro L; Talamini R; Baylink DJ
J Clin Endocrinol Metab; 1996 Feb; 81(2):542-6. PubMed ID: 8636265
[TBL] [Abstract][Full Text] [Related]
2. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared.
Bettica P; Moro L; Robins SP; Taylor AK; Talbot J; Singer FR; Baylink DJ
Clin Chem; 1992 Nov; 38(11):2313-8. PubMed ID: 1424129
[TBL] [Abstract][Full Text] [Related]
3. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
[TBL] [Abstract][Full Text] [Related]
4. Urinary galactosyl-hydroxylysine in postmenopausal osteoporotic women: A potential marker of bone fragility.
Lo Cascio V; Bertoldo F; Gambaro G; Gasperi E; Furlan F; Colapietro F; Lo Cascio C; Campagnola M
J Bone Miner Res; 1999 Aug; 14(8):1420-4. PubMed ID: 10457275
[TBL] [Abstract][Full Text] [Related]
5. Urinary output of hydroxylysine glycosides and pyridinium cross-links in detecting rat bone collagen turnover rate.
Grazioli V; Alfano M; Stenico A; Casari E
FEBS Lett; 1996 Jun; 388(2-3):134-8. PubMed ID: 8690072
[TBL] [Abstract][Full Text] [Related]
6. Ovariectomy in the rat induces a rapid increase in the urinary excretion of hydroxylysine glycosides and non-reducible crosslink residues.
Casari E; Alfano M; Valente M; Clarke GD; Ferni G; Grazioli B
Osteoporos Int; 1997; 7(6):539-43. PubMed ID: 9604049
[TBL] [Abstract][Full Text] [Related]
7. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
8. Analytical and clinical evaluation of the Bio-Rad HPLC kit for measurement of type I collagen cross links.
Srivastava AK; Libanati C; Oberrauch W; Leenings J; Greenwald M; Baylink DJ
J Bone Miner Metab; 2003; 21(3):134-44. PubMed ID: 12720047
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on biochemical markers of bone collagen breakdown in post-menopausal women.
Sirtori P; Sosio C; Polo RM; Tenni R; Rubinacci A
Pharmacol Res; 1997 Sep; 36(3):229-35. PubMed ID: 9367668
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of bone turnover for the clinical assessment of bone metabolism.
Taylor AK; Lueken SA; Libanati C; Baylink DJ
Rheum Dis Clin North Am; 1994 Aug; 20(3):589-607. PubMed ID: 7984780
[TBL] [Abstract][Full Text] [Related]
11. Galactosylhydroxylysine and pyridinium cross links in monitoring the bone response to hormone replacement therapy.
Marabini R; Sirtori P; Chionna R; Barzizza L; Rubinacci A
J Endocrinol Invest; 1996 Mar; 19(3):154-8. PubMed ID: 8743280
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus.
Kipen Y; Will R; Strauss BJ; Morand EF
Clin Rheumatol; 1998; 17(4):271-6. PubMed ID: 9776107
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of biochemical markers of bone turnover and postmenopausal osteoporosis.
Yilmaz N; Bayram M; Erbåğci AB; Kilinçer MS
Clin Chem Lab Med; 1999 Feb; 37(2):137-43. PubMed ID: 10219502
[TBL] [Abstract][Full Text] [Related]
14. Collagen cross-links as a marker for subclinical atherosclerosis in postmenopausal women.
Caglar GS; Kahyaoglu I; Ozdemir ED; Seker R; Demirtas S
Menopause; 2014 Jan; 21(1):74-8. PubMed ID: 23736860
[TBL] [Abstract][Full Text] [Related]
15. Vitamin K in combination with other biochemical markers to diagnose osteoporosis.
Heiss C; Hoesel LM; Wehr U; Keller T; Horas U; Meyer C; Rambeck W; Schnettler R
Biomarkers; 2004; 9(6):479-88. PubMed ID: 15849068
[TBL] [Abstract][Full Text] [Related]
16. Markers of bone resorption--measurement in serum, plasma or urine?
Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y
J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626
[TBL] [Abstract][Full Text] [Related]
18. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
[TBL] [Abstract][Full Text] [Related]
19. The relationship between body composition and the urinary excretion of deoxypyridinoline and galactosyl-hydroxylysine in children and adolescents.
Fricke O; Land C; Beccard R; Semler O; Stabrey A; Schoenau E
J Bone Miner Metab; 2009; 27(6):689-97. PubMed ID: 19526303
[TBL] [Abstract][Full Text] [Related]
20. Urinary markers of bone resorption, pyridinoline and deoxypyridinoline, are increased in sickle cell patients with further increments during painful crisis.
Nur E; Mairuhu W; Biemond BJ; van Zanten AP; Schnog JJ; Brandjes DP; Otten HM;
Am J Hematol; 2010 Nov; 85(11):902-4. PubMed ID: 20882525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
